VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,391 | +19.1% | 9,152 | +84.8% | 0.00% | 0.0% |
| Q2 2023 | $117,832 | +143597.6% | 4,953 | +53.9% | 0.00% | +33.3% |
| Q1 2023 | $82 | +1540.0% | 3,218 | +1874.2% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 163 | -98.0% | 0.00% | -100.0% |
| Q3 2022 | $167,000 | +406.1% | 8,173 | +189.0% | 0.00% | +200.0% |
| Q2 2022 | $33,000 | -26.7% | 2,828 | +14.1% | 0.00% | – |
| Q1 2022 | $45,000 | – | 2,478 | +247700.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -99.2% | 0.00% | – |
| Q1 2021 | $2,000 | – | 118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |